艾迪药业：拟使用不超1.00亿元暂时闲置募集资金进行现金管理

Core Viewpoint - The company has approved a plan to utilize temporarily idle raised funds for cash management, allowing for investment in low-risk, liquid financial instruments [1] Group 1: Board Meeting and Approval - The company will hold its third board meeting on February 12, 2026, to review and approve the cash management proposal [1] - The maximum amount for cash management is set at RMB 100 million [1] Group 2: Investment Duration and Conditions - The investment period for the cash management plan is from April 14, 2026, to April 13, 2027, valid for 12 months [1] - The funds can be used in a rolling manner within the approved limit [1] Group 3: Investment Direction - The investment will focus on high-security, liquid financial products such as structured deposits, agreement deposits, notice deposits, time deposits, large certificates of deposit, and income certificates [1] - The funds are not permitted to be used for pledging or for securities investment purposes [1] - The cash management activities will not affect the progress of the fundraising investment projects or the company's normal operations [1]